Andrzej Januszewicz Selected Research

Normetanephrine

1/2022	Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.
1/2022	Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
9/2018	Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging.
8/2017	Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
4/2014	Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
1/2014	Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
3/2013	Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites.
3/2013	Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej Januszewicz Research Topics

Disease

34	Hypertension (High Blood Pressure) 01/2022 - 01/2005
24	Paraganglioma (Paragangliomas) 01/2022 - 01/2004
16	Pheochromocytoma 01/2022 - 05/2002
14	Neoplasms (Cancer) 01/2022 - 08/2006
6	Hyperaldosteronism (Conn Syndrome) 10/2020 - 01/2013
4	Essential Hypertension 01/2020 - 01/2003
4	Renal Artery Obstruction (Renal Artery Stenosis) 01/2016 - 06/2003
4	Type 2 Diabetes Mellitus (MODY) 12/2014 - 02/2006
3	Heart Failure 01/2021 - 01/2013
3	Obstructive Sleep Apnea 01/2021 - 10/2011
3	Pathologic Constriction (Stenosis) 01/2021 - 12/2017
3	Adenoma (Adenomas) 01/2020 - 01/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 06/2003
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2014 - 05/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
2	Isolated Systolic Hypertension 12/2016 - 01/2011
2	Renal Insufficiency (Renal Failure) 01/2016 - 01/2012
2	Albuminuria 02/2015 - 02/2006
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2013 - 10/2011
2	Glucose Intolerance 01/2013 - 10/2011
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2010 - 05/2002
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Multiple Myeloma 01/2021
1	Amyloidosis 01/2021
1	Hypertrophy 12/2020
1	Atrial Fibrillation 09/2020
1	Vascular Remodeling 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Obesity 01/2019
1	Weight Gain 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Hypoxia (Hypoxemia) 04/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2017
1	Papilledema 01/2016
1	Hemorrhage 01/2016
1	Hyperplasia 01/2016
1	Malignant Hypertension 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Mood Disorders (Mood Disorder) 01/2016

Drug/Important Bio-Agent (IBA)

15	CatecholaminesIBA 01/2022 - 12/2006
12	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2003
9	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 05/2002
8	NormetanephrineIBA 01/2022 - 03/2013
8	MetanephrineIBA 12/2020 - 03/2013
5	3-methoxytyramine (methoxytyramine)IBA 01/2022 - 01/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2011
4	AldosteroneIBA 01/2022 - 11/2004
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 02/2006
4	Hormones (Hormone)IBA 01/2019 - 08/2006
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 04/2017
3	SodiumIBA 01/2021 - 01/2011
3	Mineralocorticoid Receptor AntagonistsIBA 10/2020 - 01/2015
3	SteroidsIBA 01/2020 - 05/2014
3	Dopamine (Intropin)FDA LinkGeneric 08/2017 - 03/2013
2	EnzymesIBA 01/2021 - 09/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2017
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2016
2	ReninIBA 01/2020 - 01/2014
2	CalciumIBA 01/2017 - 01/2013
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016 - 01/2007
2	Cystatin CIBA 02/2015 - 01/2010
2	AngiotensinsIBA 01/2014 - 11/2012
2	olmesartanIBA 04/2012 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 01/2010
2	Olmesartan Medoxomil (Votum)FDA Link 02/2006 - 01/2003
1	lipoprotein cholesterolIBA 01/2022
1	FibrinIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	finerenoneIBA 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 12/2020
1	GlucocorticoidsIBA 01/2020
1	CorticosteroneIBA 01/2020
1	Cortodoxone (11 Deoxycortisol)IBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 04/2017
1	SaltsIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2017
1	Drug CombinationsIBA 01/2017
1	DiureticsIBA 12/2016
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2016
1	mahuang-tangIBA 01/2016
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2015

Therapy/Procedure

13	Therapeutics 10/2021 - 12/2005
8	Denervation 01/2021 - 10/2011
6	Catheters 01/2021 - 01/2011
5	Adrenalectomy 10/2020 - 05/2014
4	Sympathectomy (Sympathectomies) 01/2021 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2017 - 12/2006
2	Radiotherapy 01/2013 - 12/2006
1	Stem Cell Transplantation 01/2021
1	Renal Dialysis (Hemodialysis) 01/2021